Oxurion NV Announces New NYSE Euronext Brussels Stock Ticker “OXUR” and Launch of New Website

Source: Oxurion NV

Oxurion NV announced the start of today’s trading under “OXUR” on NYSE Euronext Brussels.

Effective today, the launch of a new ticker and website (www.oxurion.com) coincides with the company’s name change and highlights its comprehensive approach and renewed focus on the development of best-in-class therapies for back of the eye disorders.

“In light of our recent developments and rebranding program, the launch of the new website reaffirms our commitment to develop disease-modifying therapies for patients living with disorders affecting the back of the eye,” Patrik De Haes, MD, CEO of Oxurion, said in a company news release. “This comes at an exciting time as we have made great strides with our clinical developments and we look forward to continuing our work to preserve vision for patients around the world by leveraging our deep scientific knowledge of diseases affecting the back of the eye.”

Related Content